FREMONT, Calif., Feb. 28 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc.
(PDL) (Nasdaq: PDLI) today announced that it will make available a live
webcast of its presentation at the Citigroup Global Healthcare Conference in
Washington, D.C. The live webcast will begin at 9:45 a.m. Eastern time on
March 1, 2006. The presentation will be made by Mark McDade, Chief Executive
Officer. The live audio webcast of the presentation will be available to all
interested parties through the PDL website at http://www.pdl.com. Please connect to
this website at least 15 minutes prior to the live webcast to allow time for
any software download that may be needed to hear the webcast. A replay will
be available at http://www.pdl.com starting approximately 24 hours after completion
of the live webcast, and will remain available for 30 days thereafter.
PDL BioPharma, Inc. is a biopharmaceutical company focused on discovering,
developing and commercializing innovative therapies for severe or life
threatening illnesses. The company currently markets and sells a portfolio of
leading products in the acute-care hospital setting in the United States and
Canada and generates royalties through licensing agreements with top-tier
biotechnology and pharmaceutical companies based on its pioneering humanized
antibody technology. Currently, PDL BioPharma's diverse late-stage product
pipeline includes six investigational compounds in Phase 2 or Phase 3 clinical
development for hepatorenal syndrome, inflammation and autoimmune diseases,
cardiovascular disorders and cancer. For more information, please see our
website at http://www.pdl.com.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks
of PDL BioPharma, Inc.
SOURCE PDL BioPharma, Inc.
 back to top
Related links:
http://www.pdl.com
CONTACT:
Ami Knoefler, Senior Director, Corporate and
Investor Relations, +1-510-284-8851, or ami.knoefler@pdl.com, or
James R. Goff, Senior Director, Investor Relations,
+1-510-574-1421, or james.goff@pdl.com, both of PDL BioPharma,
Inc.
|
